Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
蛋白結合(高分子化)ドキソルビシンの抗腫瘍効果
―多剤耐性克服への試み―
波多野 孝史大川 清滝沢 尚子松田 誠塚田 裕
著者情報
ジャーナル フリー

1993 年 8 巻 2 号 p. 111-114

詳細
抄録
Multidrug resistant (MDR) cell line, AH66DR, derived from rat ascites hepatoma AH66 parental cell, AH66P, was established and overcoming effect of conjugate of bovine serum albumin (BSA) with doxorubicin (DXR) on the cell line was examined in vitro and in vivo. The conjugate (BSA : DXR molar ratio =1 : 3.28) was accumulated in the cytoplasm of the AH66DR by reduction of efflux of the drug. The conjugate expressed the excellent antitumor activity against AH66DR (IC50=50nM) and this value was almost similar cytotoxic titer of DXR against AH66P. The conjugate also showed the most efficacious life-prolonging effect against the rats bearing AH66P as well as AH66DR cell line.
著者関連情報
© 日本DDS学会
前の記事 次の記事
feedback
Top